Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jongen-Lavrencic, Mojca"'
Autor:
Al Hinai ASA; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; National Genetic Center, Ministry of Health, Muscat, Sultanate of Oman., Grob T; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Rijken M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Kavelaars FG; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Zeilemaker A; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Erpelinck-Verschueren CAJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Sanders MA; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Löwenberg B; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Jongen-Lavrencic M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. p.valk@erasmusmc.nl.
Publikováno v:
Leukemia [Leukemia] 2021 Sep; Vol. 35 (9), pp. 2693-2697. Date of Electronic Publication: 2021 Feb 15.
Autor:
Ossenkoppele GJ; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands. g.ossenkoppele@vumc.nl, Stussi G, Maertens J, van Montfort K, Biemond BJ, Breems D, Ferrant A, Graux C, de Greef GE, Halkes CJ, Hoogendoorn M, Hollestein RM, Jongen-Lavrencic M, Levin MD, van de Loosdrecht AA, van Marwijk Kooij M, van Norden Y, Pabst T, Schouten HC, Vellenga E, Verhoef GE, de Weerdt O, Wijermans P, Passweg JR, Löwenberg B
Publikováno v:
Blood [Blood] 2012 Dec 06; Vol. 120 (24), pp. 4706-11. Date of Electronic Publication: 2012 Oct 09.
Autor:
Löwenberg B; Erasmus University Medical Center, Department of Hematology (L413), P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. b.lowenberg@erasmusmc.nl, Ossenkoppele GJ, van Putten W, Schouten HC, Graux C, Ferrant A, Sonneveld P, Maertens J, Jongen-Lavrencic M, von Lilienfeld-Toal M, Biemond BJ, Vellenga E, van Marwijk Kooy M, Verdonck LF, Beck J, Döhner H, Gratwohl A, Pabst T, Verhoef G
Publikováno v:
The New England journal of medicine [N Engl J Med] 2009 Sep 24; Vol. 361 (13), pp. 1235-48.
Autor:
Martha Arellano, Patrick J. Stiff, Geoffrey L. Uy, Sarah E. Church, Norbert Vey, Marianne Santaguida, Patrick Kaminker, Ibrahim Aldoss, Erin Fehr, Michael P. Rettig, Matthew C. Foster, Maya Kostova, Patrice Chevallier, John F. DiPersio, Peter H. Sayre, Anjali S. Advani, Erica K. Anderson, Kendra Sweet, Bob Löwenberg, Matthew J. Wieduwilt, Martin Wermke, Farhad Ravandi, Jayakumar Vadakekolathu, Ezio Bonvini, Michael Byrne, Mojca Jongen-Lavrencic, Emmanuel Gyan, Matteo Carrabba, Jan K Davidson-Moncada, John E. Godwin, Laura C. Michaelis, Gerwin Huls, Fabio Ciceri, Kenneth Jacobs, Sergio Rutella, Ouiam Bakkacha, Kristen Pettit, Christian Recher, Kathy M. Tran, Teia Curtis, Stefania Paolini, Jian Zhao, Roland B. Walter, Max S. Topp, Kuo Guo, Ashkan Emadi, John Muth, Harry P. Erba
Publikováno v:
Blood, 137(6), 751-762. American Society of Hematology
Blood
Blood, 137(6), 751-762. AMER SOC HEMATOLOGY
Blood
Blood, 137(6), 751-762. AMER SOC HEMATOLOGY
Approximately 50% of acute myeloid leukemia (AML) patients do not respond to induction therapy (primary induction failure [PIF]) or relapse after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05abb6f9a6e869b8ae72d0b4779e5546